Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: Efficacy, safety and cost-comparison

World Journal of Gastroenterology

Volumn 19, Issue 41, 2013, Pages 7106-7113

  Ertan, Atilla ^a,b,c   Zaheer, Irum ^c   Correa, Arlene M ^d   Thosani, Nirav ^a,b   Blackmon, Shanda H ^c  

^a MEMORIAL HERMANN HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Barrett's esophagus; Cost comparison; Dysplasia; Photodynamic therapy; Radiofrequency ablation

Indexed keywords

PHOTOFRIN; PROTON PUMP INHIBITOR; TENIDAP;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CATHETER; COMPARATIVE STUDY; COST; ENDOSCOPIC BIOPSY; ESOPHAGUS PERFORATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PHOTODYNAMIC THERAPY; RADIOFREQUENCY ABLATION; SAFETY; THERAPY EFFECT; DRUG THERAPY; ESOPHAGUS DYSPLASIA; HEALING; HEALTH CARE COST; LASER; PATIENT SAFETY; TREATMENT OUTCOME;

BARRETT'S ESOPHAGUS; COST COMPARISON; DYSPLASIA; PHOTODYNAMIC THERAPY; RADIOFREQUENCY ABLATION;

AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; CATHETER ABLATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DIHEMATOPORPHYRIN ETHER; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887508692     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i41.7106     Document Type: Article

References (35)

1. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 2003; 98: 1627-1633 [PMID: 12873590 DOI: 10.1111/j.1572-0241.2003.07454.x]
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146 [PMID: 15657344 DOI: 10.1093/jnci/dji024]
3. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053 [PMID: 9827707]
4. Spechler SJ. Clinical practice. Barrett's Esophagus. N Engl J Med 2002; 346: 836-842 [PMID: 11893796 DOI: 10.1056/ NEJMcp012118]
5. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999; 117: 218-228 [PMID: 10381931]
6. Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, Russo MW, Sandler RS. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128-2138 [PMID: 16848807 DOI: 10.1111/ j.1572-0241.2006.00723.x]
7. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-1831 [PMID: 16344051 DOI: 10.1053/j.gastro.2005.08.053]
8. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RK, Vasudeva RS, Dunne D, Rahmani EY, Helper DJ. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-1677 [PMID: 14724819]
9. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-467 [PMID: 12145799]
10. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383 [PMID: 21995385 DOI: 10.1056/NEJMoa1103042]
11. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140: e18-52; quiz e13 [PMID: 21376939 DOI: 10.1053/ j.gastro.2011.01.031]
12. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166-178 [PMID: 3343032]
13. Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95: 3383-3387 [PMID: 11151865 DOI: 10.1111/j.1572-0241.2000.03348.x]
14. Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology 2011; 141: 1179-186, 1186. e1 [PMID: 21723218 DOI: 10.1053/j.gastro.2011.06.055]
15. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol 2011; 106: 1231-1238 [PMID: 21577245 DOI: 10.1038/ajg.2011.153]
16. Williams VA, Watson TJ, Herbella FA, Gellersen O, Raymond D, Jones C, Peters JH. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007; 11: 1589-1597 [PMID: 17909921 DOI: 10.1007/s11605-007-0330-9]
17. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O' Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-1619 [PMID: 11375943]
18. Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol 2009; 104: 2684-2692 [PMID: 19690526 DOI: 10.1038/ajg.2009.465]
19. Ganz RA, Overholt BF, Sharma VK, Fleischer DE, Shaheen NJ, Lightdale CJ, Freeman SR, Pruitt RE, Urayama SM, Gress F, Pavey DA, Branch MS, Savides TJ, Chang KJ, Muthusamy VR, Bohorfoush AG, Pace SC, DeMeester SR, Eysselein VE, Panjehpour M, Triadafilopoulos G. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc 2008; 68: 35-40 [PMID: 18355819 DOI: 10.1016/j.gie.2007.12.015]
20. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224: 66-71 [PMID: 8678620]
21. Max Almond L, Barr H. Management controversies in Barrett's oesophagus. J Gastroenterol 2013 Jun 5; Epub ahead of print [PMID: 23736794 DOI: 10.1007/s00535-013-0816-z]
22. Wolf DS, Dunkin BJ, Ertan A. Endoscopic Radiofrequency Ablation of Barrett's Esophagus. Surg Technol Int 2012 Dec 3; XXII. pii: sti22/33; Epub ahead of print [PMID: 23292670]
23. Li YM, Li L, Yu CH, Liu YS, Xu CF. A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig Dis Sci 2008; 53: 2837-2846 [PMID: 18427992 DOI: 10.1007/s10620-008-0257-3]
24. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57: 1200-1206 [PMID: 18460553 DOI: 10.1136/gut.2007.142539]
25. van Vilsteren FG, Pouw RE, Seewald S, Alvarez Herrero L, Sondermeijer CM, Visser M, Ten Kate FJ, Yu Kim Teng KC, Soehendra N, Rösch T, Weusten BL, Bergman JJ. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011; 60: 765-773 [PMID: 21209124 DOI: 10.1136/gut.2010.229310]
26. Singh S, Sharma P. How effective is endoscopic therapy in the treatment of patients with early esophageal cancer? Nat Clin Pract Gastroenterol Hepatol 2009; 6: 70-71 [PMID: 19065128 DOI: 10.1038/ncpgasthep1330]
27. Hull MJ, Mino-Kenudson M, Nishioka NS, Ban S, Sepehr A, Puricelli W, Nakatsuka L, Ota S, Shimizu M, Brugge WR, Lauwers GY. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol 2006; 30: 114-118 [PMID: 16330950]
28. Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, Swan MP, Hopper AD, Kwan V, Bailey AA. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010; 105: 1276-1283 [PMID: 20179694 DOI: 10.1038/ajg.2010.1]
29. Ciocirlan M, Lapalus MG, Hervieu V, Souquet JC, Napoléon B, Scoazec JY, Lefort C, Saurin JC, Ponchon T. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 2007; 39: 24-29 [PMID: 17252456 DOI: 10.1055/s-2006-945182]
30. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012; 143: 336-346 [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032]
31. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005; 62: 488-498 [PMID: 16185958 DOI: 10.1016/ j.gie.2005.06.047]
32. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288 [PMID: 19474425 DOI: 10.1056/NEJMoa0808145]
33. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572 [PMID: 16630761 DOI: 10.1016/ j.cgh.2006.03.001]
34. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low-and highrisk patient subsets. Am J Gastroenterol 2000; 95: 1669-1676 [PMID: 10925966 DOI: 10.1111/j.1572-0241.2000.02196.x]
35. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630-1639 [PMID: 11375945]